GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Archived. This submission is more than a year old. Votes and new comments are closed, and some of the advice in it may have been superseded — check the community wiki for the current version.
2k
c/trialwatch·posted 1 year ago by u/laila_almeida

tried SURPASS for 11 weeks. here is what happened.

Readout Slow Clap ×1 Receipts ×3

Genuinely asking, not being difficult.

Everyone in c/compounding repeats that hazard ratio is important. I believe it, but I have never seen anyone show why, and when I search I get 4 threads of people agreeing with each other.

Is there a paper? Is there a measurement? Or is this one of those things that is true because it has been repeated since 2023?

I am not trying to be the "source?" guy. I would just like a source.

2,476 up / 441 down85% upvoted30 commentsid 6cvyd628 May 2025

30 comments

19 in this archive, depth 5

best — the order this archive was captured in

u/oskar_ibarra382 points·1 year ago

The practical rule people converge on is 28 days at fridge temperature after first puncture, and that comes from the preservative, not the peptide.

replysharereportpermalink
u/week_one_wanda254 points·1 year ago

number-needed-to-treat is the house dialect

replysharereportpermalink
u/hazard_ratio_halstats136 points·1 year ago

press release SELECT posts must be flaired until a publication exists

replysharereportpermalink
u/laila_almeidaOP445 points·1 year ago

STEP 1 readout: 96.2% mean weight loss, absolute numbers matter. Spread around that mean is enormous.

replysharereportpermalink
u/laila_almeidaOP267 points·1 year ago

STEP 1 readout: 98.9% mean weight loss, absolute numbers matter. Spread around that mean is enormous.

replysharereportpermalink
u/renal_outcomes_rMOD207 points·1 year ago

Retitled to remove editorialising. Put the evidence in the body.

replysharereportpermalink
[removed]85 points·1 year ago

[removed by moderator]

replysharereportpermalink
u/yusuf_ramos131 points·1 year ago

Phase 2 TRIUMPH looked amazing. Phase 3 trials are harder. Do not anchor on phase 2 readouts.

replysharereportpermalink
u/hazard_ratio_halstats61 points·1 year ago

the discontinuation arms are the interesting part, not the SURPASS endpoints

replysharereportpermalink
u/trialwatch_theotrial nerd15 points·1 year ago

STEP, SURMOUNT, SURPASS, SELECT, FLOW, TRIUMPH — read the appendix

replysharereportpermalink
u/rulebook_rachaelmod · c/meta104 points·1 year ago

Water content matters more than people think. If a vial is carrying residual moisture, your "10mg" is not 10mg of peptide.

replysharereportpermalink
u/nora_oyelaran81 points·1 year ago

SELECT reported a SURMOUNT hazard ratio but the absolute event rate is what changes clinical practice.

replysharereportpermalink
u/rohan_steiner-6 points·1 year ago

Disagree but this is the good kind of wrong — it is specific enough to be checked.

replysharereportpermalink
u/hub_opssite staff1 point·1 year ago

the discontinuation arms are the interesting part, not the TRIUMPH endpoints

replysharereportpermalink
u/joaquin_stanescu1 point·1 year ago

the discontinuation arms are the interesting part, not the TRIUMPH endpoints

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

replysharereportpermalink
u/cold_chromatogram310 points·1 year ago

Titration speed is a side-effect dial far more than an efficacy dial.

replysharereportpermalink
u/zaid_roos1 point·1 year ago

STEP 1 readout: 97.2% mean weight loss, absolute numbers matter. Spread around that mean is enormous.

replysharereportpermalink
u/laila_almeidaOP1 point·1 year ago·edited

Phase 2 TRIUMPH looked amazing. Phase 3 trials are harder. Do not anchor on phase 2 readouts.

replysharereportpermalink
u/rina_sobczak1 point·1 year ago

Sceptical. If this were true we would see it reflected in the data and we do not.

replysharereportpermalink
Permalinked branches
Deep branches get their own page so a single reply chain can be linked and read on its own.
About c/trialwatch

Clinical trial reading group. New readouts, protocol amendments, endpoint definitions, dropout handling, and the difference between a press release and a publication. Absolute risk reduction and number-needed-to-treat are house dialect here.

34kmembers
95submissions
Nov 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/trialwatch rules
  1. Press-release-only posts must be flaired Press Release until a publication exists.
  2. Give the trial name, phase, n, and primary endpoint in the body.
  3. Relative risk reduction alone is not a result. Show the absolute numbers.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.